Compounds having unique CB1 receptor binding selectivity and methods for their production and use
Citation
Thomas, B., Seltzman, H., & Francisco, M. Y. (2004). IPC No. U.S.Compounds having unique CB1 receptor binding selectivity and methods for their production and use (Patent No. 6825209.)
Abstract
Compounds are provided that are amide analogs of SR141716A having unique CB1 receptor selectivity and providing WIN sparing binding characteristics, pharmaceutical compositions containing the compounds and their use in a method of treatment of CB1 receptor related disorders, such as obesity, schizophrenia, memory dysfunction and marijuana abuse.